arrow
K

Karen Cui

AstraZeneca
H指数:10
被引数:3,334

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Overall survival in the OlympiA phase Ill trial of adjuvant olaparib in patients with germime pathogenic variants in BRCA1/2 and high-risk, early breast cancer

OlympiA iii期试验中辅助olaparib治疗BRCA1/2中germime致病变异和高危早期乳腺癌患者的总生存率

2022-12-01198
OAAI
VP1-2022: Pre-specified event driven analysis of Overall Survival (OS) in the OlympiA phase III trial of adjuvant olaparib (OL) in germline BRCA1/2 mutation (gBRCAm) associated breast cancer
2022-05-0113
OA
Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib
2019-12-0134
OAAI